Showing results (1-10 of 175) with videos related to
Sort By:
Pageof 18
Cancer Cell|February 15, 2022
All roads lead to targeted diffuse large B-cell lymphoma approachesPeng-Peng Xu, Yu-Jia Huo, Wei-Li ZhaoSeminars in Hematology|August 10, 2023
Circulating tumor DNA in NK/T and peripheral T cell lymphomaYu-Jia Huo, Wei-Li ZhaoBiomarker Research|July 25, 2022
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphomaYu-Jia Huo, Peng-Peng Xu, Li Wang, et al.Medical Oncology (Northwood, London, England)|June 29, 2011
Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patientsPeng-Peng Xu, Yan Wang, Yang Shen, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 28, 2017
[Prognostic Significance of Follicular Lymphoma International Prognostic Index 2 (FLIPI2) in Follicular Lymphoma Patients Treated with Rituximab Maintenance]Peng-Peng Xu, Ying Qian, Qiu-Sheng Chen, et al.Signal Transduction and Targeted Therapy|April 17, 2020
Advances in targeted therapy for malignant lymphomaLi Wang, Wei Qin, Yu-Jia Huo, et al.Hematological Oncology|July 31, 2021
Implication of immune cell signature of tumor microenvironment in diffuse large B-cell lymphomaHao Yu, Di Fu, Peng-Peng Xu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 20, 2013
[Study of prognostic related factors of elderly patients with T/NK cell lymphoma]Yong Wang, Ying Qian, Li-li Wu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 20, 2013
[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia]Bing-bing Zhao, Zheng Zhu, Peng-peng Xu, et al.Signal Transduction and Targeted Therapy|April 9, 2023
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphomaRong Shen, Di Fu, Lei Dong, et al.Pageof 18